资源类型

期刊论文 2646

会议视频 61

年份

2024 3

2023 180

2022 221

2021 219

2020 182

2019 163

2018 142

2017 149

2016 126

2015 141

2014 120

2013 85

2012 82

2011 93

2010 107

2009 108

2008 113

2007 137

2006 69

2005 60

展开 ︾

关键词

可持续发展 13

优化 9

遗传算法 9

发展战略 8

细水雾 8

能源 8

DX桩 7

人工智能 7

数值模拟 7

神经网络 7

医学 6

预测 6

COVID-19 5

机器学习 5

沉降 5

环境 5

临床试验 4

信息技术 4

多目标优化 4

展开 ︾

检索范围：

排序： 展示方式：

Exploring the methodology and application of clinical pathway in evidence-based Chinese medicine

Sicheng Wang, He Yu, Jianping Liu, Baoyan Liu

《医学前沿（英文）》 2011年 第5卷 第2期   页码 157-162 doi: 10.1007/s11684-011-0128-8

摘要： At present, clinical pathway has become one of the most important health care reform measures in many countries. In this study, the authors introduced basic concepts and explored the application of the clinical pathway of evidence-based Chinese medicine incorporated with the methodology from the concepts of management, evidence-based medicine, operational research and health economics. Such concepts provide examples and experiences, on which the application of clinical pathway in Chinese medicine practice in China can be based.

关键词： evidence-based medicine     clinical pathway     methodology     concept     technical difficulty    

HTML PDF 收藏

Translating evidence into policy in China: opportunities and challenges

Jiyao Wang, Xuejuan Jin

《医学前沿（英文）》 2011年 第5卷 第3期   页码 315-320 doi: 10.1007/s11684-011-0146-6

摘要： Research and evidence are critical for the formulation of policies and practices in support of health care. In the past two decades, the Chinese Clinical Epidemiology Network has been promoting evidence-based policy making in China. Evidence-based policy has become a major part of the government’s approach to policy making. The current article addresses the translation of evidence into health policies based on the expansion of evidence-based medicine in China. It also discusses the opportunities and challenges for certain evidence to be considered in policy making and practice in the future.

关键词： clinical epidemiology     evidence-based decision making     policy    

HTML PDF 收藏

Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies

Guangbiao Zhou, Saijuan Chen, Zhu Chen

《医学前沿（英文）》 2020年 第14卷 第2期   页码 117-125 doi: 10.1007/s11684-020-0773-x

摘要： Since the outbreak of the COVID-19 pandemic in early December 2019, 81 174 confirmed cases and 3242 deaths have been reported in China as of March 19, 2020. The Chinese people and government have contributed huge efforts to combat this disease, resulting in significant improvement of the situation, with 58 new cases (34 were imported cases) and 11 new deaths reported on March 19, 2020. However, as of March 19, 2020, the COVID-19 pandemic continues to develop in 167 countries/territories outside of China, and 128 665 confirmed cases and 5536 deaths have been reported, with 16 498 new cases and 817 new deaths occurring in last 24 hours. Therefore, the world should work together to fight against this pandemic. Here, we review the recent advances in COVID-19, including the insights in the virus, the responses of the host cells, the cytokine release syndrome, and the therapeutic approaches to inhibit the virus and alleviate the cytokine storm. By sharing knowledge and deepening our understanding of the virus and the disease pathogenesis, we believe that the community can efficiently develop effective vaccines and drugs, and the mankind will eventually win this battle against this pandemic.

关键词： COVID-19     SARS-CoV-2     pathogenesis     evidence-based medicine     control and therapeutic strategies    

HTML PDF 收藏

practice of accelerating transformation of traditional Chinese medicine from experience medicine to evidence-based

Baoyan Liu, Yanhong Zhang, Jingqing Hu, Liyun He, Xuezhong Zhou

《医学前沿（英文）》 2011年 第5卷 第2期   页码 163-170 doi: 10.1007/s11684-011-0143-9

摘要： The gradual development of Chinese medicine is based on constant accumulation and summary of experience in clinical practice, but without the benefit of undergoing the experimental medicine stage. Although Chinese medicine has formed a systematic and unique theory system through thousands of years, with the development of evidence-based medicine, the bondage of the research methods of experience medicine to Chinese medicine is appearing. The rapid transition and transformation from experience medicine to evidence-based medicine have become important content in the development of Chinese medicine. According to the features of Chinese medicine, we propose the research idea of “taking two ways simultaneously,” which is the study both in the ideal condition and in the real world. Analyzing and constructing the theoretical basis and methodology of clinical research in the real world, and building the stage for research technique is key to the effective clinical research of Chinese medicine. Only by gradually maturing and completing the clinical research methods of the real world could we realize “taking two ways simultaneously” and complementing each other, continuously produce scientific and reliable evidence of Chinese medicine, as well as transform and develop Chinese medicine from experience medicine to evidence-based medicine.

关键词： Chinese medicine     experience medicine     evidence-based medicine     real world    

HTML PDF 收藏

Practice and principle of traditional Chinese medicine for the prevention and treatment of COVID-19

《医学前沿（英文）》 doi: 10.1007/s11684-023-1040-8

摘要： Traditional Chinese medicine (TCM) has played an important role in the prevention and treatment of coronavirus disease 2019 (COVID-19) epidemic in China. The integration of Chinese and Western medicine is an important feature of Chinese COVID-19 prevention and treatment. According to a series of evidence-based studies, TCM can reduce the infection rate of severe acute respiratory syndrome coronavirus 2 in high-risk groups. For patients with mild and moderate forms of COVID-19, TCM can relieve the related signs and symptoms, shorten the period of nucleic-acid negative conversion, and reduce conversion rate to the severe form of the disease. For COVID-19 patients with severe and critical illnesses, TCM can improve inflammatory indicators and blood oxygen saturation, shorten the hospital stay, and reduce the mortality rate. During recovery, TCM can improve patients’ symptoms, promote organ function recovery, boost the quality of patients’ life, and reduce the nucleic-acid repositive conversion rate. A series of mechanism research studies revealed that capability of TCM to treat COVID-19 through antiviral and anti-inflammatory effects, immune regulation, and protection of organ function via a multicomponent, multitarget, and multipathway approach.

关键词： traditional Chinese medicine     COVID-19     SARS-CoV-2     clinical evidence-based study     mechanism     integrated traditional Chinese and Western medicine    

HTML PDF 收藏

传统中医药治疗类风湿性关节炎——从经验医学到循证医学 Review

潘胡丹, 肖瑶, 王婉莹, 任汝通, 梁丽娴 , 刘良

《工程（英文）》 2019年 第5卷 第5期   页码 895-906 doi: 10.1016/j.eng.2019.01.018

摘要：

类风湿关节炎（RA）是一种常见的自身免疫性疾病，病因难以捉摸。常规和生物疾病缓解药物有时会失效或仅产生部分反应。中药（TCM）长期以来一直在中国用作RA的治疗方法，并在世界范围内得到越来越多的接受。传统上，中医治疗以中医辨证论治为指导。但是，它们仍然依赖于中医理论和医生进行经验实践

关键词： 中药，类风湿关节炎，循证治疗，展望    

HTML PDF 收藏

New practice in semaglutide on type-2 diabetes and obesity: clinical evidence and expectation

《医学前沿（英文）》 2022年 第16卷 第1期   页码 17-24 doi: 10.1007/s11684-021-0873-2

摘要： Obesity is an important risk factor of type 2 diabetes (T2D), which has become an important factor threatening human health. However, no perfect drug choice for obesity exists. Semaglutide is a kind of human glucagon-like peptide-1 (GLP-1) analog that promotes insulin secretion while inhibiting glucagon secretion through a glucose concentration-dependent mechanism. GLP-1 can also delay stomach emptying and suppress appetite to help lose weight. This review summarizes clinical evidence of the semaglutide effect on T2D and obesity and establishes expectations on future clinical trials for obesity treatment.

关键词： semaglutide     type 2 diabetes     obesity    

HTML PDF 收藏

Clinical research of traditional Chinese medicine in big data era

null

《医学前沿（英文）》 2014年 第8卷 第3期   页码 321-327 doi: 10.1007/s11684-014-0370-y

摘要：

With the advent of big data era, our thinking, technology and methodology are being transformed. Data-intensive scientific discovery based on big data, named “The Fourth Paradigm,” has become a new paradigm of scientific research. Along with the development and application of the Internet information technology in the field of healthcare, individual health records, clinical data of diagnosis and treatment, and genomic data have been accumulated dramatically, which generates big data in medical field for clinical research and assessment. With the support of big data, the defects and weakness may be overcome in the methodology of the conventional clinical evaluation based on sampling. Our research target shifts from the “causality inference” to “correlativity analysis.” This not only facilitates the evaluation of individualized treatment, disease prediction, prevention and prognosis, but also is suitable for the practice of preventive healthcare and symptom pattern differentiation for treatment in terms of traditional Chinese medicine (TCM), and for the post-marketing evaluation of Chinese patent medicines. To conduct clinical studies involved in big data in TCM domain, top level design is needed and should be performed orderly. The fundamental construction and innovation studies should be strengthened in the sections of data platform creation, data analysis technology and big-data professionals fostering and training.

关键词： big data     traditional Chinese medicine     clinical evaluation     evidence based medicine    

HTML PDF 收藏

FMO3--TMAO axis modulates the clinical outcome in chronic heart-failure patients with reduced ejectionfraction: evidence from an Asian population

《医学前沿（英文）》 2022年 第16卷 第2期   页码 295-305 doi: 10.1007/s11684-021-0857-2

摘要： The association among plasma trimethylamine-N-oxide (TMAO), FMO3 polymorphisms, and chronic heart failure (CHF) remains to be elucidated. TMAO is a microbiota-dependent metabolite from dietary choline and carnitine. A prospective study was performed including 955 consecutively diagnosed CHF patients with reduced ejection fraction, with the longest follow-up of 7 years. The concentrations of plasma TMAO and its precursors, namely, choline and carnitine, were determined by liquid chromatography-mass spectrometry, and the FMO3 E158K polymorphisms (rs2266782) were genotyped. The top tertile of plasma TMAO was associated with a significant increment in hazard ratio (HR) for the composite outcome of cardiovascular death or heart transplantation (HR=1.47, 95% CI=1.13–1.91, P=0.004) compared with the lowest tertile. After adjustments of the potential confounders, higher TMAO could still be used to predict the risk of the primary endpoint (adjusted HR=1.33, 95% CI=1.01–1.74, P=0.039). This result was also obtained after further adjustment for carnitine (adjusted HR=1.33, 95% CI=1.01–1.74, P=0.039). The FMO3 rs2266782 polymorphism was associated with the plasma TMAO concentrations in our cohort, and lower TMAO levels were found in the AA-genotype. Thus, higher plasma TMAO levels indicated increased risk of the composite outcome of cardiovascular death or heart transplantation independent of potential confounders, and the FMO3 AA-genotype in rs2266782 was related to lower plasma TMAO levels.

关键词： chronic heart failure     trimethylamine-N-oxide     flavin monooxygenase 3     single nucleotide polymorphism    

HTML PDF 收藏

A study on specialist or special disease clinics based on big data

null

《医学前沿（英文）》 2014年 第8卷 第3期   页码 376-381 doi: 10.1007/s11684-014-0356-9

摘要：

Correlation analysis and processing of massive medical information can be implemented through big data technology to find the relevance of different factors in the life cycle of a disease and to provide the basis for scientific research and clinical practice. This paper explores the concept of constructing a big medical data platform and introduces the clinical model construction. Medical data can be collected and consolidated by distributed computing technology. Through analysis technology, such as artificial neural network and grey model, a medical model can be built. Big data analysis, such as Hadoop, can be used to construct early prediction and intervention models as well as clinical decision-making model for specialist and special disease clinics. It establishes a new model for common clinical research for specialist and special disease clinics.

关键词： big data     correlation analysis     medical information     integration     data analysis     clinical model    

HTML PDF 收藏

Ulrike Lindequist：蕈菌治疗学的循证之路（2019年9月19日）

Ulrike Lindequist(高级职称)

2021年01月20日

关键词： 生物工程    

新形势下中西医结合医学的发展思考

王聪慧,冯哲,尹智炜,李爽,陈香美

《中国工程科学》 2021年 第23卷 第2期   页码 169-174 doi: 10.15302/J-SSCAE-2021.02.016

摘要：

新型冠状病毒肺炎（ COVID-19）疫情席卷全球，中西医结合医学作为我国特有的医学模式，在抗击疫情过程中发挥了重要作用；及时总结运用经验，提升中西医结合医学事业发展水平，将为我国全民健康与医药卫生事业发展提供坚实保障。本文利用文献分析、问卷调查等方法获得的基础数据，梳理了新中国成立以来中西医结合取得的基础成绩，总结了中西医结合医学在 COVID-19 疫情防控方面发挥的关键作用；在梳理发展现状的基础上，研判了中西医结合在医疗资源、临床教育科研、国际化等方面存在的不足。研究提出了实现中西医结合继承创新、引领世界传统医药与现代医学结合发展等我国新形势下中西医结合医学的建设目标；据此建议，完善中西医结合治理体系，加强中西医结合防治人才和队伍建设，积极推动中西医结合国际交流发展，弘扬中西医结合文化。

关键词： 中西医结合医学     循证医学     评价体系     人才培养     新型冠状病毒肺炎    

HTML PDF 收藏

Preliminary clinical study on non-transecting anastomotic bulbomembranous urethroplasty

null

《医学前沿（英文）》 2017年 第11卷 第2期   页码 277-283 doi: 10.1007/s11684-017-0515-x

摘要：

This study aims to investigate the effect of non-transecting anastomotic urethroplasty for treatment of posterior urethral stricture. A total of 23 patients with traumatic posterior urethral stricture were enrolled and then divided into two groups. In one group, 12 patients underwent non-transecting anastomotic urethroplasty. In the other group, 11 patients underwent conventional posterior urethra end-to-end anastomosis. The effect of operation was evaluated using the following parameters: the bleeding amount during operation, operation time, IIEF-5 scores after operation, maximum flow rate (Qmax), and rating scale of quality of life (QoL). The comparison between the conventional posterior urethra end-to-end anastomosis group and the non-transecting anastomotic urethroplasty group showed no significant difference with regard to average operation time. However, a significant difference was observed between the groups with regard to the bleeding amount during operation. The patients in the group of non-transecting anastomotic urethroplasty urinated smoothly after the removal of catheter. Meanwhile, one patient from the group of conventional posterior urethra end-to-end anastomosis had difficulty urinating after the removal of catheter. Furthermore, significant differences in the operation time, bleeding amount during operation, IIEF-5 scores after operation, and rating scale of QoL were observed, whereas no significant difference was observed between urine flow rates of the two groups after operation. Overall, non-transecting anastomotic urethroplasty is effective for posterior urethra reconstruction, and it can reduce the occurrence rate of erectile dysfunction after operation.

关键词： anastomotic urethroplasty     transecting     posterior urethra reconstruction    

HTML PDF 收藏

Antimicrobial activity of topical agents against Propionibacterium acnes: an in vitro study of clinical

null

《医学前沿（英文）》 2016年 第10卷 第4期   页码 517-521 doi: 10.1007/s11684-016-0480-9

摘要：

This study aimed to compare the antimicrobial activities of topical agents against Propionibacterium acnes isolated from patients admitted to a hospital in Shanghai, China. The minimal inhibitory concentrations of the cultured P. acnes were determined in accordance with the Clinical and Laboratory Standards Institute. Susceptibilities to clindamycin and erythromycin were compared in terms of gender, age, disease duration, previous treatment, and disease severity. A total of 69 P. acnes strains were isolated from 98 patients (70.41%). The susceptibility to triple antibiotic ointment (neomycin/bacitracin/polymyxin B) and bacitracin was 100%. The susceptibility to fusidic acid was 92.7%. The resistance rates to neomycin sulfate, erythromycin, and clindamycin were 11.7%, 49.3%, and 33.4%, respectively. The high resistance rate to clindamycin and erythromycin was significantly affected by gender, previous treatment, and disease severity rather than by age and disease duration. Topical antibiotics should not be used separately for long-term therapy to avoid multiresistance. The use of topical antibiotics should be determined by clinicians on the basis of clinical conditions.

关键词： antimicrobial susceptibility/resistance     Propionibacterium acnes     topical antibiotics     in vitro study    

HTML PDF 收藏

Clinical efficacy of comprehensive therapy based on traditional Chinese medicine patterns on patientswith pneumoconiosis: a pilot double-blind, randomized, and placebo-controlled study

《医学前沿（英文）》 2022年 第16卷 第5期   页码 736-744 doi: 10.1007/s11684-021-0870-5

摘要： Effective therapy options for pneumoconiosis are lacking. Traditional Chinese medicine (TCM) presents a favorable prospect in the treatment of pneumoconiosis. A pilot study on TCM syndrome differentiation can evaluate the clinical efficacy and safety of TCM and lay a foundation for further clinical research. A double-blind, randomized, and placebo-controlled trial was conducted for 24 weeks, in which 96 patients with pneumoconiosis were randomly divided into the control and treatment groups. Symptomatic treatment was conducted for the two groups. The treatment group was treated with TCM syndrome differentiation, and the control group was treated with placebo. The primary outcomes were the six-minute walking distance (6MWD) and the St. George Respiratory Questionnaire (SGRQ) score. The secondary outcomes were the modified British Medical Research Council Dyspnea Scale (mMRC), Chronic Obstructive Pulmonary Disease Assessment Test (CAT), Hospital Anxiety and Depression Scale (HADS), and pulmonary function. Only 83 patients from the 96 patients with pneumoconiosis finished the study. For the primary outcome, compared with the control groups, the treatment group showed a significantly increased 6MWD (407.90 m vs. 499.51 m; 95% confidence interval (CI) 47.25 to 135.97; P <0.001) and improved SGRQ total score (44.48 vs. 25.67; 95% CI −27.87 to −9.74; P <0.001). The treatment group also significantly improved compared with the control group on mMRC score (1.4 vs. 0.74; 95% CI −1.08 to −0.23; P =0.003), CAT score (18.40 vs. 14.65; 95% CI −7.07 to −0.43; P =0.027), and the total symptom score (7.90 vs. 5.14; 95% CI −4.40 to −1.12; P <0.001). No serious adverse events occurred. This study showed that TCM syndrome differentiation and treatment had a favorable impact on the exercise endurance and quality of life of patients with pneumoconiosis.

关键词： pneumoconiosis     randomized controlled trials     traditional Chinese medicine    

HTML PDF 收藏

标题 作者 时间 类型 操作

Exploring the methodology and application of clinical pathway in evidence-based Chinese medicine

Sicheng Wang, He Yu, Jianping Liu, Baoyan Liu

期刊论文

Translating evidence into policy in China: opportunities and challenges

Jiyao Wang, Xuejuan Jin

期刊论文

Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies

Guangbiao Zhou, Saijuan Chen, Zhu Chen

期刊论文

practice of accelerating transformation of traditional Chinese medicine from experience medicine to evidence-based

Baoyan Liu, Yanhong Zhang, Jingqing Hu, Liyun He, Xuezhong Zhou

期刊论文

Practice and principle of traditional Chinese medicine for the prevention and treatment of COVID-19

期刊论文

传统中医药治疗类风湿性关节炎——从经验医学到循证医学

潘胡丹, 肖瑶, 王婉莹, 任汝通, 梁丽娴 , 刘良

期刊论文

New practice in semaglutide on type-2 diabetes and obesity: clinical evidence and expectation

期刊论文

Clinical research of traditional Chinese medicine in big data era

null

期刊论文

FMO3--TMAO axis modulates the clinical outcome in chronic heart-failure patients with reduced ejectionfraction: evidence from an Asian population

期刊论文

A study on specialist or special disease clinics based on big data

null

期刊论文

Ulrike Lindequist：蕈菌治疗学的循证之路（2019年9月19日）

Ulrike Lindequist(高级职称)

2021年01月20日

会议视频

新形势下中西医结合医学的发展思考

王聪慧,冯哲,尹智炜,李爽,陈香美

期刊论文

Preliminary clinical study on non-transecting anastomotic bulbomembranous urethroplasty

null

期刊论文

Antimicrobial activity of topical agents against Propionibacterium acnes: an in vitro study of clinical

null

期刊论文

Clinical efficacy of comprehensive therapy based on traditional Chinese medicine patterns on patientswith pneumoconiosis: a pilot double-blind, randomized, and placebo-controlled study

期刊论文